Athina Gavriilidou

Ms. Athina Gavriilidou

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BTBarbara R Terlouw
Barbara R Terlouw
KBKai Blin
Kai Blin
JNJorge C Navarro-Muñoz
Jorge C Navarro-Muñoz
NANicole Avalon
Nicole Avalon
MCMarc Chevrette
Marc Chevrette
MMMarnix H. Medema
Marnix H. Medema
With an ever-increasing amount of (meta)genomic data being deposited in sequence databases, (meta)genome mining for natural product biosynthetic pathways occupies a critical role in the discovery of novel pharmaceutical drugs, crop protection agents and biomaterials. The genes that encode these pathways are often organised into biosynthetic gene clusters (BGCs). In 2015, we defined the Minimum Information about a Biosynthetic Gene cluster (MIBiG): a standardised data format that describes the minimally required information to uniquely characterise a BGC. We simultaneously constructed an accompanying online database of BGCs, which has since been widely used by the community as a reference dataset for BGCs and was expanded to 2021 entries in 2019 (MIBiG 2.0). Here, we describe MIBiG 3.0, a database update comprising large-scale validation and re-annotation of existing entries and 661 new entries. Particular attention was paid to the annotation of compound structures and biological activities, as well as protein domain selectivities. Together, these new features keep the database up-to-date, and will provide new opportunities for the scientific community to use its freely available data, e.g. for the training of new machine learning models to predict sequence-structure-function relationships for diverse natural products. MIBiG 3.0 is accessible online at https://mibig.secondarymetabolites.org/.

2 May 2022 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
AGAthina Gavriilidou
Athina Gavriilidou
SKSatria A. Kautsar
Satria A. Kautsar
NZNestor Zaburannyi
Nestor Zaburannyi
Daniel KrugDaniel Krug
Daniel Krug
RMRolf Müller
Rolf Müller
NZNadine Ziemert
Nadine Ziemert

18 August 2021 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MCMarc Chevrette
Marc Chevrette
AGAthina Gavriilidou
Athina Gavriilidou
SMShrikant Mantri
Shrikant Mantri
Nelly Selem MojicaNelly Selem Mojica
Nelly Selem Mojica
NZNadine Ziemert
Nadine Ziemert
Francisco (Paco) Barona-GomezFrancisco (Paco) Barona-Gomez
Francisco (Paco) Barona-Gomez
The development and application of evolutionary genome mining tools and databases has propelled natural products research into the modern age of Big Data.

28 May 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
IHIra Handayani
Ira Handayani
HSHamada Saad
Hamada Saad
SRShanti Ratnakomala
Shanti Ratnakomala
PLPuspita Lisdiyanti
Puspita Lisdiyanti
WKWien Kusharyoto
Wien Kusharyoto
Yvonne MastYvonne Mast
Yvonne Mast
Indonesia is one of the most biodiverse countries in the world and a promising resource for novel natural compound producers. Actinomycetes produce about two thirds of all clinically used antibiotics. Thus, exploiting Indonesia’s microbial diversity for actinomycetes may lead to the discovery of novel antibiotics. A total of 422 actinomycete strains were isolated from three different unique areas in Indonesia and tested for their antimicrobial activity. Nine potent bioactive strains were prioritized for further drug screening approaches. The nine strains were cultivated in different solid and liquid media, and a combination of genome mining analysis and mass spectrometry (MS)-based molecular networking was employed to identify potential novel compounds. By correlating secondary metabolite gene cluster data with MS-based molecular networking results, we identified several gene cluster-encoded biosynthetic products from the nine strains, including naphthyridinomycin, amicetin, echinomycin, tirandamycin, antimycin, and desferrioxamine B. Moreover, 16 putative ion clusters and numerous gene clusters were detected that could not be associated with any known compound, indicating that the strains can produce novel secondary metabolites. Our results demonstrate that sampling of actinomycetes from unique and biodiversity-rich habitats, such as Indonesia, along with a combination of gene cluster networking and molecular networking approaches, accelerates natural product identification.

11 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAthina Gavriilidou
Athina Gavriilidou
NKNoel Kubach
Noel Kubach
MAMartina Adamek
Martina Adamek
JRJens-Peter Rodler
Jens-Peter Rodler
SKSusanna Kremer
Susanna Kremer
NZNadine Ziemert
Nadine Ziemert
Glycopeptide antibiotics (GPAs) are key agents against multidrug-resistant Gram-positive pathogens, yet both the term “glycopeptide” and the current GPA type I-V classification framework have become increasingly strained as structurally and mechanistically divergent members continue to be discovered. In particular, compounds historically grouped as “type V GPAs” differ from classical GPAs in features such as glycosylation, peptide length, and reported mode of action, raising the question of whether they belong to the same natural product class. Here, a curated dataset of GPA-associated biosynthetic gene clusters (BGCs) is analysed by combining fingerprint similarity of the products with phylogenetic analysis of the BGCs. Fingerprint-based structural similarity networks and BGC similarity comparisons reveal a pronounced separation between classical lipid II-binding GPAs (types I-IV) and type V GPAs. Multi-locus phylogenetic analyses of conserved biosynthetic components further support two deeply divergent evolutionary subclasses, consistent with subclass-specific biosynthetic signatures. Together, these results motivate a revised, unambiguous framework in which the broader class is termed xyclopeptides, comprising the subclasses dalabactins (legacy GPA types I–IV) and murobactins (legacy type V).

6 June 2022 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
AGAthina Gavriilidou
Athina Gavriilidou
SKSatria A. Kautsar
Satria A. Kautsar
NZNestor Zaburannyi
Nestor Zaburannyi
Daniel KrugDaniel Krug
Daniel Krug
RMRolf Müller
Rolf Müller
NZNadine Ziemert
Nadine Ziemert